Showing results (1031-1040 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|April 30, 2016
Pharmacokinetics and comparative bioavailability of allopurinol formulations in healthy subjectsSally A Helmy, Heba M El-Bedaiwy
Clinical Pharmacology in Drug Development|April 30, 2016
Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy menHåkan Olsson, Rikard Sandström, Anders Neijber, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranololPrasarn Manitpisitkul, Christopher R Curtin, Kevin Shalayda, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Safety and pharmacokinetics of olokizumab, an anti-IL-6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I studyKosmas Kretsos, Georg Golor, Astrid Jullion, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Bioequivalence of enalapril oral solution for treatment of pediatric hypertension and enalapril tabletsBrady S Moffett, Anthony R DiSanto, Orlando Espinosa, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Confirmation of Biosimilarity in a Pharmacokinetic/Pharmacodynamic Study in Healthy Volunteers for an Analytically Highly Similar PegfilgrastimKalpna Desai, Tina Catalano, Gurinder Rai, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female VolunteersSujatha Menon, Richard Riese, Ronnie Wang, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Population pharmacokinetics of recombinant factor VIII Fc fusion proteinIvan Nestorov, Srividya Neelakantan, Thomas M Ludden, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Assessment of relative bioavailability of two presentations of moroctocog alfa (AF-CC) in subjects with moderately severe or severe hemophilia AFrank Shafer, Robert J Charnigo, Anna Plotka, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
An open-label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal functionFranklin K Johnson, Paul N Mudd, Tara DiMino, et al.
Pageof 136